Table 2.

Interval percentiles (number of days) for colorectal and breast cancer patients by area of residence

Rural residenceUrban residence
SampleCancerIntervaln (missing)Median (IQR)90th percentilen (missing)Median (IQR)90th percentile
SymptomaticCRCPatient151 (9%)28 (2–86)262151 (12%)22 (2–78)276
(n = 337)Primary care85 (51%)7 (0–47)117100 (42%)9 (0–28)74
Diagnostic149 (11%)37 (10–104)186158 (8%)27 (10–64)160
Treatment160 (4%)14 (0–30)55164 (4%)14 (4–26)44
Health system144 (15%)60 (22–126)201153 (11%)42 (27–88)157
Total132 (20%)99 (44–212)365130 (24%)79 (35–165)325
BCPatient107 (2%)6 (1–31)121148 (5%)10 (1–57)171
(n = 265)Primary care66 (39%)11 (7–22)37108 (31%)7 (3–14)35
Diagnostic107 (2%)10 (5–21)46150 (4%)12 (7–21)45
Treatment107 (2%)18 (11–28)36154 (1%)13 (7–24)37
Health system105 (4%)31 (21–44)71148 (5%)28 (19–45)67
Total101 (7%)40 (29–93)208140 (10%)45 (30–99)192
Symptomatic and screen-detectedCRCDiagnostic179 (14%)37 (10–89)156190 (16%)27 (9–63)139
(n = 433)Treatment199 (4%)16 (1–31)51216 (4%)14 (2–26)43
Total160 (23%)92 (43–184)360161 (29%)70 (28–133)264
BCDiagnostic190 (7%)14 (6–27)52263 (7%)15 (7–27)41
(n = 489)Treatment201 (2%)19 (11–28)37280 (1%)15 (9–27)37
Total182 (11%)42 (29–70)148251 (12%)43 (28–65)127
  • NOTE: Median, 50th percentile; IQR, interquartile range – 25th, 75th percentiles; 90th percentile – 90% of patients have an interval length within this time.

  • Abbreviations: BC, breast cancer; CRC, colorectal cancer.